Associated partners
University Hospital Würzburg
In a clinical trial in the DZIF research area Infections of the Immunocompromised Host, leukaemia patients receive specially purified cells of the immune system, so-called memory T cells, after bone marrow transplantation. The special immune cells are intended to protect the patients from infections until their own immune defences function. Some of the study patients will be treated in Würzburg, as well as at the DZIF partner sites in Munich (coordination), Tübingen and Hannover-Braunschweig.